Abstract: Fertility preservation for cancer patients is a relatively new field in medicine which requires interdisciplinary approach. Improving therapies and rising survival rates require to consider patient's quality of life after cancer is cured which is relevant personal issue regardless of the individual income and the level of development of the country of origin. Fertility preservation offers possible solution but also raises ethical questions. We provide a summary of ethical principles embodied in professional guidelines together with options and restrictions to access fertility preservation in developing countries. We also make a suggestion that oncofertility counselling could be a pillar to address fertility preservation issues in cancer patients. Our proposed decisional support model is patient centred and focuses on patient values, personal philosophy and view of life emphasizing sensitivity to individual patient's needs and wishes. Some fertility preservation concerns in oncology might be addressed mirroring already available expertise while some others will call for innovative and region specific solutions. Therefore, in addition to our proposal we also provide a list of organisations working in oncofertility field.
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ethical practices for a few years, while the situation in developing countries is less clear. Some of already existing expertise could be applied globally acknowledging that there might be new region and culture specific concerns which will require innovation and creative approach in order to reach a solution. This article aims to show that fertility preservation for cancer patients is globally relevant, because cancer incidence is increasing even in developing countries. The quality of life after cancer treatment is a relevant personal issue regardless the individual income and the level of development of the country of origin. Existing fertility preservation options allow cancer patients to have a possibility to enjoy parenthood in the future. However, it also raises a number of ethical concerns. Professional guidelines from around the globe reflect on a number of ethical principles which we present in a light of opportunities and restrictions patients in the developing countries might face. Considering global obstacles to access fertility preservation services, we suggest that a thorough oncofertility counselling for all cancer patients could be the first pillar to address fertility issues in cancer patients. We also provide a decisional support model which focuses on patient values and provide a short overview of resources available online to establish an effective oncofertility counselling service in oncology hospitals.
Cancer Survival Worldwide: Cancer survival rates are increasing and life after cancer is a real possibility for many patients worldwide. This is why it is also important to speak about life after cancer and take steps to ensure a good quality of life for cancer survivors even before cancer treatment begins. In Europe about one third of adult cancers have a relative 5-year survival rate greater that 80% 4 , combined 5-year survival rates for all childhood cancers is ranging from 70% to 82% 5 . Similar 5-year survival rates for adult and childhood cancers are available from the United States, Canada and Australia 6, 7, 8, 9 . China, South Korea, Singapore and Turkey have slightly lower relative 5-year cancer survival rates ranging between 44-82% 10 and Brazil below 60% 7 . There is no much data from African countries where survival does not exceed13-22%. In the Gambia and Uganda with exception of breast cancer survival reaching 43% 10 , reports on childhood cancer survival rates vary widely 11 .
However, it is estimated that the number of cancer cases in African countries will increase significantly by 2030 12 
.
Lower survival rates in developing countries are most likely due to late diagnosis and limited availability of standard treatments 13 , the same problem is reported in Eastern European countries 4, 7 .
Cancer is predominantly associated with older age, even though it also affects children, adolescents and young adults. Survival rates are known to be the highest for patients aged between 15 and 44 years old 4 . Childhood cancers represent 1% of all recorded malignancies 14 . Moreover, epidemiological data from the USA and Europe also suggests that there has been an increase in childhood cancer incidence by 1% each year 15, 16 23 .
Other fertility preservation methods are less well established and still considered experimental.
Ovarian and testicular tissue cryopreservation is the sole fertility preservation method available for prepubertal children 21 . It is still highly experimental and there is no proven benefit that patients who had their fertility preserved using these methods will be able to benefit from them in the future.
Ovarian tissue cryopreservation has been used as fertility preservation methods in adult women and nearly 30 live births have been reported using this method 24 . However, there is still no certainty if it can successfully be used when ovarian tissue was obtained from prepubertal ovaries.
Following the guidelines, all cancer patients and /or their parents or guardians should be informed about cancer treatment effects on future fertility and physicians should discuss available options to preserve fertility. Usually there are time constrains to consider all available options because in many cases cancer treatment has to be initiated as soon as possible to achieve good health outcomes.
However, despite available guidelines and established methods, recent review of oncologists' attitudes and practices revealed that not all physicians are prepared to discuss fertility related issues with their patients indicating that concerns about patient's prognosis, lack of knowledge and sometimes personal biases prevent them from addressing fertility preservation needs adequately 25 .
Meanwhile, patients are interested to receive fertility preservation consultation and appreciate such information as part of shared decision making even if they choose not to preserve their fertility before cancer treatment commences 26 . A number of recent studies suggest that nearly half of cancer patients do not receive appropriate fertility preservation counselling 25, 27 . Moreover, in many instances female patients are informed and proceed with fertility preservation less often than men 28, 29 . However, despite of fertility importance for female patients it has been reported that globally only less than 10 % would accept lower chances to survival in order to preserve fertility 30 .
Ethical Implications of Currently Followed Practices:
As it has been shown above, current fertility preservation practices for cancer patients are still far from perfection. Oncofertility field is still new and being multi-disciplinary requires innovative solutions and close cooperation among different healthcare providers. It brings up some new ethical issues but a good number of ethical concerns relating to fertility preservation in oncology are not new, they just have to be addressed in a different light 31 . The following questions are still lacking comprehensive answers in the literature but they could help to initiate a self reflection on developing a personal stand on fertility preservation issue in general.
Medicine: How do we set treatment priorities? Is it appropriate to delay cancer treatment to preserve the chance to have biological child if patient survives? Could doctor's suggestion to preserve fertility
give false hopes about survival? In bioethics literature fertility treatment is not always seen as a positive right where every individual is enabled to procreate 35 . However, right to reproduce is often defended as ability to bear autonomy, personal identity, self-determination and possession of dignity where infertility can be addressed as disability 36 . Concerns can be raised that the hype of fertility preservation options give patients the false hope of survival and future fertility even if the goal of cancer treatment is to cure with the least amount of damage and side effects. Moreover, when physician feels that risks of doing so outweighs the benefits, fertility preservation procedures could be denied or patient referred to another 
Options and Restrictions for Fertility Preservation in Developing Countries:
Technologies and skills can travel easily around the globe but sometimes restrictions including cultural and religious acceptability, financial constraints and lack of local expertise or regulation are met. Unfortunately, there is very little data on available services and how often cancer patients in developing countries use them. As resources in developing countries are usually scarce, it could be argued that fertility preservation is not a primary health concern, because it is not a medically necessary procedure. However, people without children, especially women, can often be seen as having lower social status and experience ostracism by other members of their society 38 . This implies that fertility preservation is an important and relevant issue globally and should not be ignored.
Nonetheless, the following obstacles are found in the developing world. .
Cultural and religious obstacles:
Geographic obstacles and lack of trained specialists: Medical centres providing fertility preservation services have scarce geographical distribution in developed countries and there are even fewer of them in developing countries. Long travelling distance, and the related expenses, could be one of main restrictions for patients in developing countries to use fertility preservation services. It might also be difficult to find fertility specialist and even be referred to one. Very few studies from non
Western countries report that more than half oncologists do not have enough knowledge about fertility preservation to feel comfortable in discussing it with their patients 40, 41, 42 . Counsellors should primarily inform patients both on medical conditions and their implications on future life, and also provide information about fertility preservation options. Moreover, they should be able to identify patient's wishes and expectations. Counsellors should also be knowledgeable of local legislation, be prepared to handle patient's emotions, have sensitivity to patients spiritual or religious needs, and be ready to evaluate which fertility preservation options can be affordable, when resources are limited.
Lack of regulation or legal restrictions on fertility preservation methods:

Resources for Ethical Practice:
These are offered by a number of organisations worldwide. The
Oncofertility Consortium based at Northwestern University in Chicago (USA) pioneered fertility preservation in Oncology and provides online tools for oncofertility communication. Professional guidelines from the USA and Europe suggest that all cancer patients should be informed about treatment effect on their future fertility and available fertility preservation options should also be discussed. However, there are still communication problems induced by lack of time and expertise followed by personal biases held by physicians when initiating discussion on fertility preservation with a patient.
Next to the information provided to all cancer patients about treatment effect on fertility and fertility preservation options other core principles allow parents to act in order to preserve fertility for their children, accept the use of PDG to avoid serious inherited conditions in the offspring, do not justify the denial of reproductive services based on the concerns about the welfare of the future child. Moreover, patients should be referred to other relevant specialists and support services when needed and given time to reflect on fertility preservation discussion and possible choices before making decisions.
There is very little data on fertility preservation services and how often cancer patients use them in developing countries. Cultural and religious constraints, financial restrains, long distance to the facilities and lack of trained specialists as well as lack of regulation and legal restrictions on fertility preservation methods are often met in developed countries and can be relevant globally.
Our proposal is that despite of limited resources fertility preservation issues in cancer patients should be addressed regardless the individual income and the level of development of the country of origin. A set up of ethical oncofertility practice can be started though oncofertility counselling where providing quality decision support services for all cancer patients. Such service would help patient to understand his or her medical condition and possible solutions while reflecting on personal philosophy and view of life which usually shape patient's goals, wishes and expectations. Counsellors will play an important role and in addition to medical knowledge and communication skills will need to be knowledgeable of local legislation, have sensitivity to patient's religious and spiritual needs, be ready to handle patient's emotions and also help patient to evaluate which fertility preservation options could be affordable when resources are limited.
